Global Pharma-Grade Nitric Oxide Market Report (2025–2035)

1. Market Overview of Pharma-Grade Nitric Oxide
    1.1 Pharma-Grade Nitric Oxide Market Overview
        1.1.1 Pharma-Grade Nitric Oxide Product Scope
        1.1.2 Market Status and Outlook
    1.2 Pharma-Grade Nitric Oxide Market Size by Regions:
    1.3 Pharma-Grade Nitric Oxide Historic Market Size by Regions
    1.4 Pharma-Grade Nitric Oxide Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Pharma-Grade Nitric Oxide Sales Market by Type
    2.1 Global Pharma-Grade Nitric Oxide Historic Market Size by Type
    2.2 Global Pharma-Grade Nitric Oxide Forecasted Market Size by Type
    2.3 99.92%?Purity
    2.4 99.99%?Purity
    2.5 Others
3. Covid-19 Impact Pharma-Grade Nitric Oxide Sales Market by Application
    3.1 Global Pharma-Grade Nitric Oxide Historic Market Size by Application
    3.2 Global Pharma-Grade Nitric Oxide Forecasted Market Size by Application
    3.3 Hospitals
    3.4 Healthcare Centers
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Pharma-Grade Nitric Oxide Production Capacity Market Share by Manufacturers
    4.2 Global Pharma-Grade Nitric Oxide Revenue Market Share by Manufacturers
    4.3 Global Pharma-Grade Nitric Oxide Average Price by Manufacturers
5. Company Profiles and Key Figures in Pharma-Grade Nitric Oxide Business
    5.1 Inomax
        5.1.1 Inomax Company Profile
        5.1.2 Inomax Pharma-Grade Nitric Oxide Product Specification
        5.1.3 Inomax Pharma-Grade Nitric Oxide Production Capacity, Revenue, Price and Gross Margin
    5.2 Praxair
        5.2.1 Praxair Company Profile
        5.2.2 Praxair Pharma-Grade Nitric Oxide Product Specification
        5.2.3 Praxair Pharma-Grade Nitric Oxide Production Capacity, Revenue, Price and Gross Margin
    5.3 Air Liquide
        5.3.1 Air Liquide Company Profile
        5.3.2 Air Liquide Pharma-Grade Nitric Oxide Product Specification
        5.3.3 Air Liquide Pharma-Grade Nitric Oxide Production Capacity, Revenue, Price and Gross Margin
    5.4 Novoteris
        5.4.1 Novoteris Company Profile
        5.4.2 Novoteris Pharma-Grade Nitric Oxide Product Specification
        5.4.3 Novoteris Pharma-Grade Nitric Oxide Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Pharma-Grade Nitric Oxide Market Size
    6.2 North America Pharma-Grade Nitric Oxide Key Players in North America
    6.3 North America Pharma-Grade Nitric Oxide Market Size by Type
    6.4 North America Pharma-Grade Nitric Oxide Market Size by Application
7. East Asia
    7.1 East Asia Pharma-Grade Nitric Oxide Market Size
    7.2 East Asia Pharma-Grade Nitric Oxide Key Players in North America
    7.3 East Asia Pharma-Grade Nitric Oxide Market Size by Type
    7.4 East Asia Pharma-Grade Nitric Oxide Market Size by Application
8. Europe
    8.1 Europe Pharma-Grade Nitric Oxide Market Size
    8.2 Europe Pharma-Grade Nitric Oxide Key Players in North America
    8.3 Europe Pharma-Grade Nitric Oxide Market Size by Type
    8.4 Europe Pharma-Grade Nitric Oxide Market Size by Application
9. South Asia
    9.1 South Asia Pharma-Grade Nitric Oxide Market Size
    9.2 South Asia Pharma-Grade Nitric Oxide Key Players in North America
    9.3 South Asia Pharma-Grade Nitric Oxide Market Size by Type
    9.4 South Asia Pharma-Grade Nitric Oxide Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Pharma-Grade Nitric Oxide Market Size
    10.2 Southeast Asia Pharma-Grade Nitric Oxide Key Players in North America
    10.3 Southeast Asia Pharma-Grade Nitric Oxide Market Size by Type
    10.4 Southeast Asia Pharma-Grade Nitric Oxide Market Size by Application
11. Middle East
    11.1 Middle East Pharma-Grade Nitric Oxide Market Size
    11.2 Middle East Pharma-Grade Nitric Oxide Key Players in North America
    11.3 Middle East Pharma-Grade Nitric Oxide Market Size by Type
    11.4 Middle East Pharma-Grade Nitric Oxide Market Size by Application
12. Africa
    12.1 Africa Pharma-Grade Nitric Oxide Market Size
    12.2 Africa Pharma-Grade Nitric Oxide Key Players in North America
    12.3 Africa Pharma-Grade Nitric Oxide Market Size by Type
    12.4 Africa Pharma-Grade Nitric Oxide Market Size by Application
13. Oceania
    13.1 Oceania Pharma-Grade Nitric Oxide Market Size
    13.2 Oceania Pharma-Grade Nitric Oxide Key Players in North America
    13.3 Oceania Pharma-Grade Nitric Oxide Market Size by Type
    13.4 Oceania Pharma-Grade Nitric Oxide Market Size by Application
14. South America
    14.1 South America Pharma-Grade Nitric Oxide Market Size
    14.2 South America Pharma-Grade Nitric Oxide Key Players in North America
    14.3 South America Pharma-Grade Nitric Oxide Market Size by Type
    14.4 South America Pharma-Grade Nitric Oxide Market Size by Application
15. Rest of the World
    15.1 Rest of the World Pharma-Grade Nitric Oxide Market Size
    15.2 Rest of the World Pharma-Grade Nitric Oxide Key Players in North America
    15.3 Rest of the World Pharma-Grade Nitric Oxide Market Size by Type
    15.4 Rest of the World Pharma-Grade Nitric Oxide Market Size by Application
16 Pharma-Grade Nitric Oxide Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

• 99.92% Purity
• 99.99% Purity
• Others

By Application

• Hospitals
• Healthcare Centers

Regional Analysis

• North America (U.S., Canada, Mexico): Mature market with strong demand in respiratory therapies and advanced healthcare infrastructure.
• Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by regulatory frameworks and adoption in critical care units.
• Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by expanding healthcare systems and rising investments in advanced therapies.
• South America (Brazil, Argentina): Emerging opportunities in hospital infrastructure and respiratory care.
• Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and modernization of healthcare facilities.

Key Players

• Inomax (Mallinckrodt Pharmaceuticals)
• Praxair (Linde Group)
• Air Liquide
• Novoteris
• Additional Notable Players: BOC Healthcare, Matheson Tri-Gas, Messer Group, Air Products & Chemicals